Ocean Biomedical, Inc.

Ocean Biomedical, Inc., listed under the ticker AEHA on Nasdaq, is a biopharmaceutical company that completed its de-SPAC business combination with Aesther Healthcare Acquisition Corp. in February 2023. The blank-check vehicle, sponsored by Aesther Healthcare Management LLC, conducted its initial public offering in 2021 targeting the healthcare and life sciences sector. Ocean Biomedical, which originated from research conducted at Brown University, is focused on developing novel therapeutics across oncology, infectious disease, and pulmonary fibrosis. The company filed an 8-K current report with the SEC on April 1, 2025, continuing its post-merger disclosure obligations as a publicly traded entity. For complete filing history and SPAC deal analytics on AEHA, create a free account at SpacDesk.